Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Jun 25, 2024 • 3 minute read Article content First Commercial Agreement for DispersinB® WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) …